Homocysteine

check icon Optimal Result: 3.7 - 10.4 umol/L.

Homocysteine (Hcy) is not a classic amino acid found in dietary protein. Homocysteine’s only source in humans is the demethylation of s-adenosylmethionine (SAM).

Homocysteine is a major branch point in the methylation pathway. It can be metabolized via two pathways: degraded irreversibly through the transsulfuration pathway or re-methylated back to methionine. These two pathways are greatly affected by vitamin and mineral cofactor availability and enzymatic SNPs. [L]

Transsulfuration is the main route for irreversible Homocysteine disposal. Transsulfuration begins when Homocysteine is converted to cystathionine, using the cystathionine β-synthase enzyme (CBS). This reaction requires nutrient cofactors, such as vitamin B6 and iron.

Alternatively, Homocysteine can be re-methylated back to methionine. [L] Two distinct routes exist for Hcy remethylation. The first reaction is dependent on folate and vitamin B12. The second route for Homocysteine remethylation is independent of folate, but requires betaine. The betaine pathway for Homocysteine remethylation is a salvage pathway when folate metabolism abnormalities are present or in folate deficiency. [L] Under normal conditions, the body will remethylate Homocysteine several times before allowing irreversible transsulfuration. [L]

Whereas SAM-dependent methylation occurs in nearly all tissues, the transsulfuration pathway and Homocysteine remethylation occur primarily in the liver and kidneys. [L]

Homocysteine intracellular concentration is under tight control. As mentioned above, SAH accumulation must be avoided as it can inhibit all methylation reactions. Because of AHCY’s reversible nature, it is mandatory that intracellular Homocysteine concentrations are kept within strict limits. Optimal Homocysteine concentrations in cells are maintained or re-established through folate-dependent remethylation.

Whenever the cellular capacity to metabolize Homocysteine is exceeded, this amino acid will be exported to the extracellular space until intracellular levels are normalized. This results in elevated plasma Homocysteine levels. Exceptions are liver and kidney cells, where Homocysteine can enter the transsulfuration pathway.

Several factors can affect Homocysteine metabolism causing hyperhomocysteinemia. These include B-vitamin deficiencies, impaired renal excretion, advanced age, sex (male), smoking, alcohol, and genetic enzyme deficiencies. [L]

Elevated homocysteine levels have many clinical implications:

- Hyperhomocysteinemia is regarded as a risk factor for non-coronary atherosclerosis and coronary artery disease. Elevated homocysteine enhances vascular smooth-muscle cell proliferation, increases platelet aggregation, and acts on the coagulation cascade and fibrinolysis, causing normal endothelium to become more thrombotic. The mechanism may be related to elevations in SAH, due to the reversible nature of Hcy formation. [L] SAH has been shown to be a more sensitive marker in many diseases as previously outlined. [L], [L

- Diabetes, both type 1 and type 2, initially causes hypohomocysteinemia, due to renal hyperperfusion early in the diabetic nephropathy disease process. This progresses to hyperhomocysteinemia as renal function becomes compromised. [L], [L]

- Elevated homocysteine levels have also been implicated in gastrointestinal disorders such as inflammatory bowel disease and colon cancer. [L], [L] Hyperhomocysteinemia may be partially due to nutrient malabsorption (methyl donor and B-vitamin deficiency). Subsequently, elevated Hcy has been shown to induce inflammatory cytokines and contribute to disease progression. [L]

- Homocysteine can impair bone health by interfering with osteoclast activity. The increased Hcy impairs the cellular and molecular mechanism of bone marrow- derived osteoclasts by causing imbalance between phosphorylation and de-phosphorylation of various protein kinases that modulate bone cell remodeling. [L]

Homocysteinemia contributes to neurodegenerative diseases (Alzheimer’s and Parkinson’s diseases) and mood disorders. [L], [L], [L]

Elevated Hcy increases CNS phosphorylated tau leading to increased neurofibrillary tangle formation, seen in Alzheimer’s dementia. [L]

Hyperhomocysteinemia related to mood disorders may be multifactorial. Elevated Hcy causes elevations in SAH, which interferes

with many methyltransferase reactions involved in neurotransmitter synthesis and metabolism. Hcy may also have direct neurotoxic effects. Research is ongoing regarding the exact mechanisms regarding Hcy and psychiatric disorders. [L], [L]

Possible treatmenet options:

Dietary supplementation with folate, vitamin B12, and SAM has been shown to effectively lower plasma homocysteine levels and improve outcomes. [L], [L], [L]

Additional Note:

When referring to Hcy, the terms ‘homocysteine’ and ‘homocystine’ are used interchangeably. However, the reduced sulfhydryl form is ‘homocysteine,’ while the oxidized disulfide form is ‘homocystine.’ The composite of both forms are routinely described by the term ‘homocysteine. [L]

Most conventional laboratories that offer homocysteine measurement are actually measuring a total of homocystine, homocysteine, and SAH. To note, Genova’s Methylation Panel measures SAH and homocysteine as separate clinically significant entities. Homocystine (an oxidized form of homocysteine) is not measured by Genova. SAH and homocystine levels are negligible as compared to homocysteine, though direct comparisons have not yet been done by Genova.

----------------------

References:

- Schalinske KL, Smazal AL. Homocysteine imbalance: a pathological metabolic marker. Adv Nutr. 2012;3(6):755-762. [L]

- Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inher Metab Dis. 2006;29(1):3-20 [L]

- Stabler SP, Lindenbaum J, Savage DG, Allen RH. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood. 1993;81(12):3404-3413. [L]

- Williams KT, Schalinske KL. New insights into the regulation of methyl group and homocysteine metabolism. J Nutr. 2007;137(2):311-314. [L]

- Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr. 2001;74(6):723-729. [L]

- Wagner C, Koury MJ. S-Adenosylhomocysteine - a better indicator of vascular disease than homocysteine. Am J Clin Nutr. 2007;86(6):1581-1585. [L]

- Poirier LA, Brown AT, Fink LM, et al. Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism. 2001;50(9):1014-1018. [L]

- Behera J, Bala J, Nuru M, Tyagi SC, Tyagi N. Homocysteine as a pathological biomarker for bone disease. J Cell Physiol. 2017;232(10):2704-2709. [L]

- Gariballa S. Testing homocysteine-induced neurotransmitter deficiency, and depression of mood hypothesis in clinical practice. Age Ageing. 2011;40(6):702-705. [L]

- Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psych. 2008;79(4):368-376. [L]

- Obeid R, Schadt A, Dillmann U, Kostopoulos P, Fassbender K, Herrmann W. Methylation status and neurodegenerative markers in Parkinson disease. Clin Chem. 2009;55(10):1852- 1860. [L]

- Popp J, Lewczuk P, Linnebank M, Cvetanovska G, Smulders Y, Kölsch H. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer’s disease. J Alzheimers Dis. 2009;18. [L]

- Kevere L, Purvina S, Bauze D, et al. Elevated serum levels of homocysteine as an early prognostic factor of psychiatric disorders in children and adolescents. Schizophr Res Treatment. 2012;2012:373261. [L]

- Hei G, Pang L, Chen X, et al. [Association of serum folic acid and homocysteine levels and 5, 10-methylenetetrahydrofolate reductase gene polymorphism with schizophrenia]. Zhonghua yi xue za zhi. 2014;94(37):2897-2901. [L]

- Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Int Med. 2001;161(5):695-700. [L]

- Plasma Homocyst(e)ine or Homocysteine New Engl J Med. 1995;333(5):325-325. [L]

- DeStefano Vea. Linkage disequilibrium at the cystathionine beta-synthase (CBS) locus and the association between genetic variation at the CBS locus and plasma levels of homocysteine. Ann Human Genet. 1998;62(6):481-490. [L]

- Turner MA, Yang X, Yin D, Kuczera K, Borchardt RT, Howell PL. Structure and function of S-adenosylhomocysteine hydrolase. Cell Biochem Biophys. 2000;33(2):101-125. [L]

- Cullen CE, Carter GT, Weiss MD, Grant PA, Saperstein DS. Hypohomocysteinemia: a potentially treatable cause of peripheral neuropathology- Phys Med Rehab Clin. 2012;23(1):59-65. [L]

- Ohuchi S, Matsumoto Y, Morita T, Sugiyama K. High-casein diet suppresses guanidinoacetic acid-induced hyperhomocysteinemia and potentiates the hypohomocysteinemic effect of serine in rats. Biosci Biotechnol Biochem. 2008;72(12):3258-3264. [L]

- Kawakami Y, Ohuchi S, Morita T, Sugiyama K. Hypohomocysteinemic effect of cysteine is associated with increased plasma cysteine concentration in rats fed diets low in protein and methionine levels. J Nutr Sci Vitaminol. 2009;55(1):66-74. [L]

- Ho V, Massey TE, King WD. Effects of methionine synthase and methylenetetrahydrofolate reductase gene polymorphisms on markers of one-carbon metabolism. Genes Nutr. 2013;8(6):571- 580. [L]

- Obeid R. The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway. Nutrients. 2013;5(9):3481-3495. [L]

- Gaughan DJ, Kluijtmans LA, Barbaux S, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis. 2001;157(2):451-456. [L]

- Ueland PM. Choline and betaine in health and disease. J Inher 20. Metab Dis. 2011;34(1):3-15. [L]

- van der Gaag MS, Ubbink JB, Sillanaukee P, Nikkari S, Hendriks HF. Effect of consumption of red wine, spirits, and beer on serum homocysteine. Lancet. 2000;355(9214):1522. [L]

- O’Callaghan P, European Cg, Meleady R, et al. Smoking and plasma homocysteine. Eur Heart J. 2002;23(20):1580-1586. [L]

What does it mean if your Homocysteine result is too high?

- Vitamin B6 or iron deficiency (CBS enzyme cofactors)

- Enzymatic deficiency in MTR/MTRR/BHMT [L], [L], [L]

- Folate deficiency with low choline intake [L]

- Alcohol [L]

- Tobacco [L]

-------------------

Elevated levels are associated with:

– Atherosclerosis and coronary artery disease

– Osteopenia

– Neurodegenerative conditions – Mood disorders

– IBD and colon cancer risk

--------------------

A chronic elevation in homocysteine levels results in a parallel increase in intracellular or plasma SAH, which is a more sensitive biomarker of cardiovascular disease than homocysteine and suggests that SAH is a critical pathological factor in homocysteine-associated disorders. Previous reports indicate that supplementation with folate and B vitamins efficiently lowers homocysteine levels but not plasma SAH levels, which possibly explains the failure of homocysteine-lowering vitamins to reduce vascular events in several recent clinical intervention studies.

All Your Lab Results.
One Simple Dashboard.

What does it mean if your Homocysteine result is too low?

- Unknown clinical significance

- May be a sign of over-methylation, though literature not available

- CBS SNP in the presence of oxidative stress or inflammation [L], [L]

- AHCY deficiency (lack of vitamin B3) [L]

--------------

The clinical implications associated with low homocysteine levels are not well represented in literature. Furthermore, there is no consensus on what constitutes a ‘low level’ or if it is something that needs correcting.

However, because Hcy is used to make glutathione and is remethylated to maintain methionine levels, the theoretical importance of low Hcy exists. Without Hcy, glutathione production is compromised. Excessive oxidative stress may accelerate the transsulfuration pathway toward glutathione production, which can lower Hcy. A SNP in the CBS enzyme accelerates homocysteine transsulfuration, which may result in a low Hcy.

Many ‘methylation experts’ and key opinion leaders teach that low plasma homocysteine leads to disease and can be cancer-producing; therefore it should be corrected. Many recommend protein and sulfur-containing foods, as well as evaluating for excessive oxidative stress and decreasing methyl support. There is currently no literature that has looked at correcting low plasma homocysteine.

Literature is evolving to include low Hcy implications; however, the only literature-based clinical correlation currently available is an association with peripheral neuropathy. [L] There are a few animal studies looking for implications, physiologic impacts, and treatment strategies to correct hypohomocysteinemia, but currently no human studies exist. [L], [L]

Laboratories

Bring All Your Lab Results Together — In One Place

We accept reports from any lab, so you can easily collect and organize all your health information in one secure spot.

lab corp logo
genova diagnostics logo
quest diagnostics logo
dutch test logo
doctors data logo
vibrant america logo
diagnostic solutions logo
zrt laboratory logo
the great plains laboratory logo
cyrex laboratories logo
spectracell logo

Pricing Table

decoration

Personal plans

$15/ month

Complete Plan

Access your lab reports, explanations, and tracking tools.

  • Import lab results from any provider
  • Track all results with visual tools
  • Customize your reference ranges
  • Export your full lab history anytime
  • Share results securely with anyone
  • Begin with first report entered
  • Cancel or upgrade anytime

$250/ once

Unlimited Account

Pay once, access everything—no monthly fees, no limits.

  • Import lab results from any provider
  • Track all results with visual tools
  • Customize your reference ranges
  • Export your full lab history anytime
  • Share results securely with anyone
  • Receive 10 reports entered for you
  • Skip the $15/month subscription — no recurring payments ever

$45/ month

Pro Monthly

Designed for professionals managing their clients' lab reports

  • Import lab results from any provider
  • Track lab results for multiple clients
  • Customize reference ranges per client
  • Export lab histories and reports
  • Begin with first report entered by us
  • Cancel or upgrade anytime

About membership

What's included in a Healthmatters membership

microscope icon Import Lab Results from Any Source

person icon See Your Health Timeline

book icon Understand What Your Results Mean

textbook icon

textbook icon Visualize Your Results

folder icon

folder icon

card icon Securely Share With Anyone You Trust

Let Your Lab Results Tell the Full Story

What Healthmatters Members Are Saying

5 stars rating

I have been using Healthmatters.io since 2021. I travel all over the world and use different doctors and health facilities. This site has allowed me to consolidate all my various test results over 14 years in one place. And every doctor that I show this to has been impressed. Because with  any health professional I talk to, I can pull up historical results in seconds. It is invaluable. Even going back to the same doctor, they usually do not have the historical results from their facility in a graph format. That has been very helpful.

Anthony

Unlimited Plan Member since 2021

5 stars rating

What fantastic service and great, easy-to-follow layouts! I love your website; it makes it so helpful to see patterns in my health data. It's truly a pleasure to use. I only wish the NHS was as organized and quick as Healthmatters.io. You've set a new standard for health tracking!

Karin

Advanced Plan Member since 2020

5 stars rating

As a PRO member and medical practitioner, Healthmatters.io has been an invaluable tool for tracking my clients' data. The layout is intuitive, making it easy to monitor trends and spot patterns over time. The ability to customize reports and charts helps me present information clearly to my clients, improving communication and outcomes. It's streamlined my workflow, saving me time and providing insights at a glance. Highly recommended for any practitioner looking for a comprehensive and user-friendly solution to track patient labs!

Paul

Healthmatters Pro Member since 2024

Use promo code to save 10% off any plan.

Frequently asked questions

Healthmatters is a personal health dashboard that helps you organize and understand your lab results. It collects and displays your medical test data from any lab in one secure, easy-to-use platform.

  • Individuals who want to track and understand their health over time.
  • Health professionals, such as doctors, nutritionists, and wellness coaches, need to manage and interpret lab data for their clients.

With a Healthmatters account, you can:

  • Upload lab reports from any lab
  • View your data in interactive graphs, tables, and timelines
  • Track trends and monitor changes over time
  • Customize your reference ranges
  • Export and share your full lab history
  • Access your results anytime, from any device

Professionals can also analyze client data more efficiently and save time managing lab reports.

Healthmatters.io personal account provides in-depth research on 4000+ biomarkers, including information and suggestions for test panels such as, but not limited to:

  • The GI Effects® Comprehensive Stool Profile,
  • GI-MAP,
  • The NutrEval FMV®,
  • The ION Profile,
  • Amino Acids Profile,
  • Dried Urine Test for Comprehensive Hormones (DUTCH),
  • Organic Acids Test,
  • Organix Comprehensive Profile,
  • Toxic Metals,
  • Complete Blood Count (CBC),
  • Metabolic panel,
  • Thyroid panel,
  • Lipid Panel,
  • Urinalysis,
  • And many, many more.

You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.

If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.

shield icon

We implement proven measures to keep your data safe.

At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.

gdpr compliance image hipaa compliance image